Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZX11
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,206
Award facts
- Contract value 100% obligated
- $21,205.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on June 2, 2025, for the supply of Nucala 100 mg/mL auto-injectors, with a contract ceiling value of $21,205.69. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a direct fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. Performance will be conducted from the contractor's Park Ridge, Illinois facility.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, holds a significant single-award IDC with DLA valued at $499.99 million through November 2026, positioning the company as a critical supplier within the federal pharmaceutical supply chain for Department of Defense healthcare systems. The parent IDC covers a comprehensive portfolio of pharmaceutical products including prescription medications, biologics, and specialty items to support military health facilities nationwide. This delivery order for Nucala, a biologic asthma and eosinophilic disease treatment, exemplifies the company's role in distributing specialty pharmaceutical products to federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZX11?
SPE2DB25FZX11 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FZX11 worth?
The government has obligated $21,206 on SPE2DB25FZX11.
Is contract SPE2DB25FZX11 an order under another contract?
Yes. SPE2DB25FZX11 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX11 competed?
The extent of competition for SPE2DB25FZX11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award